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An investigation in Panama found that Punta Toro virus 
species complex (PTVs) may contribute to febrile illnesses 
with symptoms mirroring those of dengue fever. However, 
further studies are needed to determine if PTV infection 
causes only a mild disease or if it can have more serious 
manifestations in some patients.
Acute febrile illness in the New World tropics has a broad differential diagnosis largely dependent on lo-
cale and seasonal outbreaks. In Central America, most fe-
brile illnesses have historically been attributed to dengue 
or malaria. However, recent evidence from Panama sug-
gests varied differential diagnoses, including hantavirus, 
chikungunya virus, and Zika virus infection (1,2). In 2009, 
a dengue outbreak was reported in Panama City, Panama. 
The Gorgas Memorial Institute in Panama City tested den-
gue-negative samples from this outbreak for alphaviruses, 
flaviviruses, and phleboviruses and detected Punta Toro vi-
rus species complex (PTVs) in some samples. PTV (genus 
Phlebovirus, family Bunyaviridae), a member of the sand 
fly fever group, was initially described in humans in 1966 
after being isolated from a soldier in Panama who had fever, 
headache, myalgia, and leukopenia (3). The phylogenetics 
of PTV have been thoroughly characterized (4–6), but our 
search of the literature did not reveal reports of other PTV 
cases in humans.
The signs and symptoms of sand fly–associated 
phlebovirus infection vary, but most infections cause a 
mild febrile illness characterized by retroorbital headache, 
weakness, back pain, and leukopenia. However, infection 
with 2 other phleboviruses, mosquitoborne Rift Valley fe-
ver virus and tick-associated severe fever with thrombo-
cytopenia syndrome virus, causes severe disease. Little is 
known regarding the signs, symptoms, and clinical course 
of PTV infection in humans.
During the 2009 investigation, the Gorgas Memorial 
Institute analyzed 4,852 samples from persons in Panama 
with suspected acute dengue; 1,667 (34.4%) of the sam-
ples were dengue-negative. We further analyzed 201 of 
these samples for phlebovirus (online Technical Appendix 
Table 1, https://wwwnc.cdc.gov/EID/article/23/5/16-1925-
Techapp1.pdf). In brief, we extracted viral RNA from the 
samples and evaluated it by using Phlebovirus genus–spe-
cific reverse transcription PCR (RT-PCR) based on the 
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highly conserved L (large) gene that detects Toscana, Na-
ples, Sicilian, Aguacate, Punta Toro, and Rift Valley fever 
viruses (7). We also screened samples using panflavivirus 
and panalphavirus RT-PCRs. 
Of the 201 samples, 27 (13.4%) were RT-PCR–posi-
tive for phlebovirus. BLAST (https://blast.ncbi.nlm.nih.
gov/Blast.cgi) nucleotide sequence comparison suggested 
all were PTVs; 1 was previously described as Cocle vi-
rus (4). We conducted phylogenetic analyses on 11 of the 
phlebovirus-positive samples, using a 482-nt sequence and 
MEGA7 software (8). An optimal maximum-likelihood 
tree confirmed the samples were PTVs; all samples from 
2009 (GenBank accession nos. KY43355–KY435365) 
clustered together close to Cocle virus (online Technical 
Appendix Table 2) (4). Our attempts to isolate virus were 
unsuccessful. To determine if PTV had been previously de-
tected, we tested 202 randomly selected dengue virus–neg-
ative samples from 2008; none was phlebovirus-positive.
Clinical data sheets were available for 92.6% (25/27) 
of the PTV-positive samples. After de-identifying the data, 
we entered it into a dataset. A control group consisted of 
90 dengue virus–positive patients from 2009 who were fre-
quency matched by age and randomly selected from avail-
able records. The PTV-positive case-patients were largely 
located in the Panama City metropolitan area (Figure). 
Case-patients and controls were compared primarily with 
regard to reported symptoms (online Technical Appendix 
Table 3). Case-patients were significantly less likely than 
controls to have exanthema (22% vs. 54%; odds ratio 0.23, 
95% CI 0.08–0.66; p = 0.01). We found no major clinical 
differences between case-patients and controls with regard 
to other symptoms. No patients in either group had shock 
or hemorrhagic syndrome.
Febrile syndromes in the tropics are often treated em-
pirically; clinical decisions are often made on the basis 
of epidemiologic information and concurrent outbreaks. 
In Central America, dengue fever and malaria are treated 
without confirmatory testing because testing is costly and 
time-consuming. However, an increasing number of agents 
responsible for causing febrile illnesses have been identi-
fied in recent years. The variety of clinical outcomes ob-
served with hantavirus and dengue, chikungunya, and 
Zika virus infections underscores the need for more accu-
rate diagnostics to differentiate between causative agents. 
Clinical decisions must rely on accurate diagnoses because 
symptomatology is not an accurate predictor of the true eti-
ology of a febrile illness.
Our findings suggest that, in Panama, PTVs may be a 
major contributor to febrile illnesses with symptoms mir-
roring those of dengue fever. However, the clinical course 
and range of disease caused by PTVs are unknown. Pro-
spective studies are needed to determine if PTV infection 
causes only mild disease or if it can have serious manifesta-
tions in some patients. 
PTVs are assumed to be sand fly–borne, and sand flies 
are usually present in rural or forested areas (9). However, 
most cases of PTVs infection in Panama in 2009 were in 
urban and periurban areas, raising questions about the vec-
tor, the vector’s habitat, and the mode of virus transmission. 
Panama City, however, is home to two thirds of the coun-
try’s population and has improved healthcare infrastruc-
ture, which may explain the higher number of confirmatory 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 5, May 2017 873
RESEARCH LETTERS
Figure. Distribution of confirmed 
Punta Toro species complex 
infections, Panama, 2009. Dots 
indicate cases. Inset shows 
enlargement of Panama City area. 
tests from Panama City versus other areas of Panama and 
might result in a sampling bias. Despite these limitations, 
the recent Zika outbreak has shown the speed at which vec-
torborne diseases can spread and highlights the importance 
of detecting emerging viruses like PTVs.
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We report intestinal carriage of an extended-spectrum 
β-lactamase−producing Klebsiella pneumoniae strain 
with high-level resistance to colistin (MIC 24 mg/L) in a 
patient in France who had been hospitalized for fungal 
meningitis. The strain had the mcr-1 plasmid gene and 
an inactivated mgrB gene, which are associated with 
colistin resistance.
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